Medtronic and the Medtronic Foundation Expand COVID-19 Support to More Than $46 Million USD

Medtronic and the Medtronic Foundation note with the pandemic surging across the globe and food insecurity on the rise, Medtronic today announced an additional $3.8 million commitment to provide healthcare worker support and protection, mental health support, operational support, and food assistance to organizations and communities in need.

This new commitment is in addition to charitable contributions made earlier this year and brings the total of the company’s COVID-19 relief efforts to more than $46 million.

Today’s comprehensive global response focuses on emergency food assistance and hunger relief programs, mental health support and health worker grants, organization operational support, and in-kind personal protective equipment (PPE) donations in underserved communities and those disproportionately impacted by the pandemic such as Black, Indigenous, and People of Color (BIPOC) communities.

The PPE donation includes more than 400,000 N95 surgical masks and 430,000 KN95 respirators, all of which will be distributed by International Medical Corps. The masks will go to hospitals and health facilities chosen for their locations in COVID-19 hot spots, or directly to individuals as part of prevention efforts. In addition, these facilities serve underserved and underinsured communities, most at-risk and most affected by the pandemic.

“As the global pandemic continues to surge, our Mission compels us to help ensure our courageous frontline healthcare workers have adequate protection,” said Noel Colón, Medtronic senior vice president and chief quality officer. “We are proud to equip frontline health workers delivering critical care to those in need, as well as those most at-risk and most affected by the pandemic.”

Among the nonprofit organizations receiving added support from the Medtronic Foundation through its $1.6 million grant package are those focusing on rapid access to low income communities such as the COVID-19 Action Fund for Africa, Americares, Direct Relief, Meals on Wheels, and numerous food banks.

“As the coronavirus pandemic surges around the world and in our own backyard, healthcare, food assistance, and mental health pressures are at all-time highs; it is crucial for us to deliver support quickly to counteract the disproportionate effect the virus has on underserved, marginalized communities,” said Paurvi Bhatt, president of the Medtronic Foundation. “In this season of giving, we are also turning our gratitude into action by coming together with our partners to support these issues and the brave frontline health workers who are in need of services themselves.”

In addition to the financial contributions, the Medtronic Foundation also will continue to match Medtronic employee and retiree donations to approved nonprofit organizations worldwide including those that focus on food assistance, mental health support and healthcare worker protections.

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”